Rhythm Pharmaceuticals, Inc. (RYTM)
86.96
+0.67
(+0.78%)
USD |
NASDAQ |
Apr 06, 16:00
86.96
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals SG&A Expense (TTM) : 194.94M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 9.602M |
| Eli Lilly & Co. | 11.09B |
| Merck & Co., Inc. | 10.73B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| MannKind Corp. | 229.86M |